|
⚲
|
| Keyboard |
| Rapport Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0002012593 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0002012593] | |
| 10-Q | [0002012593] | |
| 3 | [0002012593] | |
| 4 | [0002012593] | |
| 8-K | [0002012593] | |
| SC 13D | [0002012593] | |
| SC 13G | [0002012593] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rapport Therapeutics Inc | |
| Ceesay Abraham | |
| Gault Cheryl | |
| Perez Robert J | |
| Paul Steven M | |
| Silva Paul M | |
| Healy James | |
| Huber Reid M | |
| Young Wendy B | |
| Sanchez Ramiro | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-30 | Sell | 7,161 | $28.04 | 200,794 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-30 | Sell | 2,839 | $28.55 | 81,053 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-25 | Sell | 10,115 | $29.99 | 303,349 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-03-05 | Sell | 2,014 | $28.93 | 58,265 |
|
Rapport Therapeutics Inc RAPP
Stock Options (Right to Buy) · derivative
|
2026-02-19 | Option exercise | 6,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-19 | Option exercise | 6,000 | $1.80 | 10,800 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-18 | Sell | 2,281 | $29.80 | 67,974 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-18 | Sell | 3,552 | $29.05 | 103,186 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-18 | Sell | 2,100 | $29.80 | 62,580 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-18 | Sell | 2,983 | $29.04 | 86,626 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-17 | Sell | 5,400 | $28.95 | 156,330 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-17 | Sell | 2,200 | $29.59 | 65,098 |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-02-17 | Sell | 900 | $28.02 | 25,218 |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 132,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 130,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 428,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 148,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 120,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 103,000 | $0.00 | |
|
Rapport Therapeutics Inc RAPP
Common Stock
|
2026-01-20 | Sell | 5,083 | $26.11 | 132,717 |
| showing 20 of 112 most recent transactions | |||||